Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma.
Protein phosphatase magnesium-dependent 1δ (PPM1D) is an oncogene, overexpressed in many solid tumors, including ovarian cancer and breast cancer. The current study examined the expression and the prognostic value of PPM1D mRNA in human hepatocellular carcinoma (HCC).Total RNA was extracted from 86...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3610683?pdf=render |
id |
doaj-1655dca5af524e9d8bba86151d50f3ba |
---|---|
record_format |
Article |
spelling |
doaj-1655dca5af524e9d8bba86151d50f3ba2020-11-24T21:45:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e6077510.1371/journal.pone.0060775Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma.Guang-Bing LiXue-Li ZhangLi YuanQi-Qi JiaoDe-Jie LiuJun LiuProtein phosphatase magnesium-dependent 1δ (PPM1D) is an oncogene, overexpressed in many solid tumors, including ovarian cancer and breast cancer. The current study examined the expression and the prognostic value of PPM1D mRNA in human hepatocellular carcinoma (HCC).Total RNA was extracted from 86 HCC and paired non-cancerous liver tissues. PPM1D mRNA expression was determined by real-time quantitative reverse transcriptase-polymerase chain reaction (qPCR). Immunohistochemistry assay was used to verify the expression of ppm1d protein in the HCC and non-cancerous liver tissues. HCC patients were grouped according to PPM1D mRNA expression with the average PPM1D mRNA level in non-cancerous liver tissue samples as the cut-off. Correlations between clinicopathologic variables, overall survival and PPM1D mRNA expression were analyzed.PPM1D mRNA was significantly higher in HCC than in the paired non-cancerous tissue (p<0.01). This was confirmed by ppm1d staining. 56 patients were classified as high expression group and the other 30 patients were categorized as low expression group. There were significant differences between the two groups in term of alpha-fetoprotein (α-FP) level (p<0.01), tumor size (p<0.01), TNM stage (p<0.01), recurrence incidence (p<0.01) and family history of liver cancer (p<0.01). The current study failed to find significant differences between the two groups in the following clinical characteristics: age, gender, portal vein invasion, lymphnode metastasis, hepatitis B virus (HBV) infection and alcohol intake. Survival time of high expression group was significantly shorter than that of low expression group (median survival, 13 months and 32 months, respectively, p<0.01).Up-regulation of PPM1D mRNA was associated with progressive pathological feature and poor prognosis in HCC patients. PPM1D mRNA may serve as a prognostic marker in HCC.http://europepmc.org/articles/PMC3610683?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Guang-Bing Li Xue-Li Zhang Li Yuan Qi-Qi Jiao De-Jie Liu Jun Liu |
spellingShingle |
Guang-Bing Li Xue-Li Zhang Li Yuan Qi-Qi Jiao De-Jie Liu Jun Liu Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. PLoS ONE |
author_facet |
Guang-Bing Li Xue-Li Zhang Li Yuan Qi-Qi Jiao De-Jie Liu Jun Liu |
author_sort |
Guang-Bing Li |
title |
Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. |
title_short |
Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. |
title_full |
Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. |
title_fullStr |
Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. |
title_full_unstemmed |
Protein phosphatase magnesium-dependent 1δ (PPM1D) mRNA expression is a prognosis marker for hepatocellular carcinoma. |
title_sort |
protein phosphatase magnesium-dependent 1δ (ppm1d) mrna expression is a prognosis marker for hepatocellular carcinoma. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
Protein phosphatase magnesium-dependent 1δ (PPM1D) is an oncogene, overexpressed in many solid tumors, including ovarian cancer and breast cancer. The current study examined the expression and the prognostic value of PPM1D mRNA in human hepatocellular carcinoma (HCC).Total RNA was extracted from 86 HCC and paired non-cancerous liver tissues. PPM1D mRNA expression was determined by real-time quantitative reverse transcriptase-polymerase chain reaction (qPCR). Immunohistochemistry assay was used to verify the expression of ppm1d protein in the HCC and non-cancerous liver tissues. HCC patients were grouped according to PPM1D mRNA expression with the average PPM1D mRNA level in non-cancerous liver tissue samples as the cut-off. Correlations between clinicopathologic variables, overall survival and PPM1D mRNA expression were analyzed.PPM1D mRNA was significantly higher in HCC than in the paired non-cancerous tissue (p<0.01). This was confirmed by ppm1d staining. 56 patients were classified as high expression group and the other 30 patients were categorized as low expression group. There were significant differences between the two groups in term of alpha-fetoprotein (α-FP) level (p<0.01), tumor size (p<0.01), TNM stage (p<0.01), recurrence incidence (p<0.01) and family history of liver cancer (p<0.01). The current study failed to find significant differences between the two groups in the following clinical characteristics: age, gender, portal vein invasion, lymphnode metastasis, hepatitis B virus (HBV) infection and alcohol intake. Survival time of high expression group was significantly shorter than that of low expression group (median survival, 13 months and 32 months, respectively, p<0.01).Up-regulation of PPM1D mRNA was associated with progressive pathological feature and poor prognosis in HCC patients. PPM1D mRNA may serve as a prognostic marker in HCC. |
url |
http://europepmc.org/articles/PMC3610683?pdf=render |
work_keys_str_mv |
AT guangbingli proteinphosphatasemagnesiumdependent1dppm1dmrnaexpressionisaprognosismarkerforhepatocellularcarcinoma AT xuelizhang proteinphosphatasemagnesiumdependent1dppm1dmrnaexpressionisaprognosismarkerforhepatocellularcarcinoma AT liyuan proteinphosphatasemagnesiumdependent1dppm1dmrnaexpressionisaprognosismarkerforhepatocellularcarcinoma AT qiqijiao proteinphosphatasemagnesiumdependent1dppm1dmrnaexpressionisaprognosismarkerforhepatocellularcarcinoma AT dejieliu proteinphosphatasemagnesiumdependent1dppm1dmrnaexpressionisaprognosismarkerforhepatocellularcarcinoma AT junliu proteinphosphatasemagnesiumdependent1dppm1dmrnaexpressionisaprognosismarkerforhepatocellularcarcinoma |
_version_ |
1725906469697617920 |